These changes reduce the p-AKT/AKT and p-GSK3β/GSK3β ratios and significantly increase the Bax/Bcl-2 ratio, resulting in suppressed CRC cell proliferation and enhanced apoptosis (Luo et al., 2023). The gene discussed is AKT1; the disease is colorectal carcinoma.